You have full text access to this OnlineOpen article

Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung

  1. D.J. Musk Jr.,
  2. P.J. Hergenrother

Article first published online: 18 FEB 2008

DOI: 10.1111/j.1365-2672.2008.03751.x

Issue

Journal of Applied Microbiology

Journal of Applied Microbiology

Volume 105, Issue 2, pages 380–388, August 2008

Additional Information

How to Cite

Musk, D.J. and Hergenrother, P.J. (2008), Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung. Journal of Applied Microbiology, 105: 380–388. doi: 10.1111/j.1365-2672.2008.03751.x

Author Information

  1. Department of Chemistry, Center of Advanced Materials for the Purification of Water with Systems, Roger Adams Lab, University of Illinois, Urbana, IL, USA

*Paul J. Hergenrother, Department of Chemistry, University of Illinois, 261 Roger Adams Lab, 600 S. Matthews Ave., Urbana, IL 61801, USA. E-mail: hergenro@uiuc.edu

Publication History

  1. Issue published online: 11 JUL 2008
  2. Article first published online: 18 FEB 2008
  3. 2007/0983: received 22 June 2007, revised 19 December 2007 and accepted 7 January 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (302K)

References

  • Banin, E., Vasil, M.L. and Greenberg, E.P. (2005) Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci USA 102, 11076–11081.
  • Banin, E., Brady, K.M. and Greenberg, E.P. (2006) Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 72, 2064–2069.
  • Beenken, K.E., Dunman, P.M., McAleese, F., Macapagal, D., Murphy, E., Projan, S.J., Blevins, J.S. and Smeltzer, M.S. (2004) Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 186, 4665–4684.
  • Berlutti, F., Ajello, M., Bosso, P., Morea, C., Petrucca, A., Antonini, G. and Valenti, P. (2004) Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans. Biometals 17, 271–278.
  • Bosco, M.C., Rapisarda, A., Reffo, G., Massazza, S., Pastorino, S. and Varesio, L. (2003) Macrophage activating properties of the tryptophan catabolite picolinic acid. Adv Exp Med Biol 527, 55–65.
  • Brown, D.A., Chidambaram, M.V., Clarke, J.J. and McAleese, D.M. (1978) Design of iron (III) chelates in oral treatment of anemia: solution properties and absorption of iron (III) acetohydroxamate in anemic rats. Bioinorg Chem 9, 255–275.
  • Cheer, S.M., Waugh, J. and Noble, S. (2003) Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. Drugs 63, 2501–2520.
  • Costerton, J.W., Stewart, P.S. and Greenberg, E.P. (1999) Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322.
  • Davidson, D.J. and Rolfe, M. (2001) Mouse models of cystic fibrosis. Trends Genet 17, S29–S37.
  • Dunbar, C. and Mitchell, J. (2005) Analysis of cascade impactor mass distributions. J Aerosol Med 18, 439–451.
  • Geller, D.E., Pitlick, W.H., Nardella, P.A., Tracewell, W.G. and Ramsey, B.W. (2002) Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis. Chest 122, 219–226.
  • Geske, G.D., Wezeman, R.J., Siegel, A.P. and Blackwell, H.E. (2005) Small molecule inhibitors of bacterial quorum sensing and biofilm formation. J Am Chem Soc 127, 12762–12763.
  • Gillis, R.J. and Iglewski, B.H. (2004) Azithromycin retards Pseudomonas aeruginosa biofilm formation. J Clin Microbiol 42, 5842–5845.
  • Glansdorp, F.G., Thomas, G.L., Lee, J.K., Dutton, J.M., Salmond, G.P.C., Welch, M. and Spring, D.R. (2004) Synthesis and stability of small molecule probes for Pseudomonas aeruginosa quorum sensing modulation. Org Biomol Chem 2, 3329–3336.
  • Grubb, B.R. and Boucher, R.C. (1999) Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 79, S193–S214.
  • Hentzer, M. and Givskov, M. (2003) Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infection. J Clin Invest 112, 1300–1307.
  • Hentzer, M., Riedel, K., Rasmussen, T.B., Heydorn, A., Andersen, J.B., Parsek, M.R., Rice, S.A., Eberl, L. et al. (2002) Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148, 87–102.
  • Hirohashi, S., Uchida, H., Yoshikawa, K., Fujita, N., Ohtomo, K., Yuasa, Y., Kawamura, Y. and Matsui, O. (1994) Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI. Magn Reson Imaging 12, 837–846.
  • Huigens, R.W., Richards, J.J., Parise, G., Ballard, T.E., Zeng, W., Deora, R. and Melander, C. (2007) Inhibition of Pseudomonas aeruginosa biofilm formation with bromoageliferin analogues. J Am Chem Soc 129, 6966–6967.
  • Johnson, M., Cockayne, A., Williams, P.H. and Morrissey, J.A. (2005) Iron-responsive regulation of biofilm formation in Staphylococcus aureus involves fur-dependent and fur-independent mechanisms. J Bacteriol 187, 8211–8215.
  • Junker, L.M. and Clardy, J. (2007) High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development. Antimicrob Agents Chemother 51, 3582–3590.
  • Katoh, S., Toyama, J., Kodama, I., Kamiya, K., Akita, T. and Abe, T. (1992) Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts. Eur Surg Res 24, 349–355.
  • Kirisits, M.J. and Parsek, M.R. (2006) Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities? Cell Microbiol 8, 1841–1849.
    Direct Link:
  • Kontoghiorghes, G.J., Eracleous, E., Economides, C. and Kolnagou, A. (2005) Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56–252, L1NA11 and their combinations. Curr Med Chem 12, 2663–2681.
  • Li, Z. and Engelhardt, J.F. (2003) Progress toward generating a ferret model of cystic fibrosis by somatic cell nuclear transfer. Reprod Biol Endocrinol 1, 83.
  • Manefield, M., DeNys, R., Kumar, N., Read, R., Givskov, M., Steinberg, P. and Kjelleberg, S. (1999) Evidence that halogenated furanones from Delisea pulchra inhibit acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein. Microbiology 145, 283–291.
  • Martinhon, C.C., Italiani Fde, M., Padilha Pde, M., Bijella, M.F., Delbem, A.C. and Buzalaf, M.A. (2006) Effect of iron on bovine enamel and on the composition of the dental biofilm formed “in situ”. Arch Oral Biol 51, 471–475.
  • Matsui, H., Wagner, V.E., Hill, D.B., Schwab, U.E., Rogers, T.D., Button, B., Taylor, R.M. II, et al. (2006) A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci USA 103, 18131–18136.
  • McGuigan, M.A. (1996) Acute iron poisoning. Pediatr Ann 25, 33–38.
  • Mitchell, J.P. and Nagel, M.W. (2003) Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. J Aerosol Med 16, 341–377.
  • Murphy, T.D., Anbar, R.D., Lester, L.A., Nasr, S.Z., Nickerson, B., VanDevanter, D.R. and Colin, A.A. (2004) Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease. Pediatr Pulmonol 38, 314–320.
    Direct Link:
  • Musk, D.J., Banko, D.A. and Hergenrother, P.J. (2005) Iron salts perturb biofilm formation and disrupt existing biofilms of Pseudomonas aeruginosa. Chem Biol 12, 789–796.
  • Musk, D.J. Jr and Hergenrother, P.J. (2006) Chemical countermeasures for the control of bacterial biofilms: effective compounds and promising targets. Curr Med Chem 13, 2163–2177.
  • Olsen, J.A., Severinsen, R., Rasmussen, T.B., Hentzer, M., Givskov, M. and Nielsen, J. (2002) Synthesis of new 3- and 4-substituted analogues of acyl homoserine lactone quorum sensing autoinducers. Bioorg Med Chem Lett 12, 325–328.
  • Parsek, M.R. and Singh, P.K. (2003) Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57, 677–701.
  • Ren, D., Bedzyk, L.A., Thomas, S.M., Ye, R.W. and Wood, T.K. (2004) Gene expression in Escherichia coli biofilms. Appl Microbiol Biotechnol 64, 515–524.
  • Rosenstein, I.J. and Hamilton-Miller, J.M. (1984) Inhibitors of urease as chemotherapeutic agents. Crit Rev Microbiol 11, 1–12.
  • Sauer, K., Camper, A.K., Ehrlich, G.D., Costerton, J.W. and Davies, D.G. (2002) Psuedomonas aeruginosa displays multiple phenotypes as a biofilm. J Bacteriol 184, 1140–1154.
  • Sermet-Gaudelus, I., Le Cocguic, Y., Ferroni, A., Clairicia, M., Barthe, J., Delaunay, J.P., Brousse, V. and Lenoir, G. (2002) Nebulized antibiotics in cystic fibrosis. Paediatr Drugs 4, 455–467.
  • Shak, S. (1995) Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Chest 107, 65S–70S.
  • Singh, P.K., Schaefer, A.L., Parsek, M.R., Moninger, T.O., Welsh, M.J. and Greenberg, E.P. (2000) Quorum sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762–764.
  • Singh, P.K., Parsek, M.R., Greenberg, E.P. and Welsh, M.J. (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417, 552–555.
  • Suri, R. (2005) The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis. BioDrugs 19, 135–144.
  • Taniguchi, M., Imamura, H., Shirota, T., Okamatsu, H., Fujii, Y., Toba, M. and Hashimoto, F. (1991) Improvement in iron deficiency anemia through therapy with ferric ammonium citrate and vitamin C and the effects of aerobic exercise. J Nutr Sci Vitaminol (Tokyo) 37, 161–171.
  • Umbreit, J. (2005) Iron deficiency: a concise review. Am J Hematol 78, 225–231.
    Direct Link:
  • Van Delden, C. and Iglewski, B.H. (1998) Cell-to-cell signaling and Pseudomonas aeruginosa infection. Emerg Infect Dis 4, 551–560.
  • Wolf-Rainer, A. (2006) Controlling biofilms of Gram-positive pathogenic bacteria. Curr Med Chem 13, 1509–1524.
  • Yang, L., Barken, K.B., Skindersoe, M.E., Christensen, A.B., Givskov, M. and Tolker-Nielsen, T. (2007) Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa. Microbiology 153, 1318–1328.
  • Zu, L.D. and Hider, R.C. (2002) Design of iron chelators with therapeutic application. Coord Chem Rev 232, 151–171.
View Full Article (HTML) Get PDF (302K)